Jeffrey Robert Ajer
SVP, Chief Commercial Of, BioMarin Pharmaceutical.
Companies
- Viridian Therapeutics, Inc.\DEBoard member Apr 9, 2025 to now1
- Nektar TherapeuticsBoard member Sep 21, 2017 to now2
- BioMarin PharmaceuticalSVP, Chief Commercial Of Sep 14, 2012 to May 6, 20243
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
BioMarin Pharmaceutical BMRN66,767 shares4$3.7M at $54.68May 2, 2024- Nektar Therapeutics NKTR4,277 shares5$161.3K at $37.72Sep 23, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 23, 2026Granted 2,000 shares of Nektar Therapeutics5
- May 2, 2024Sold 5,000 shares at $82.91 of BioMarin Pharmaceutical4
- Apr 30, 2024Granted 300 shares at $68.65 of BioMarin Pharmaceutical4
- Mar 15, 2024Shares withheld for tax 22,580 shares at $83.87 of BioMarin Pharmaceutical6
- Mar 5, 2024Sold 4,000 shares at $87.07 of BioMarin Pharmaceutical7
- Feb 27, 2024Granted 6,465 shares of BioMarin Pharmaceutical8
- Feb 27, 2024Granted 9,338 shares of BioMarin Pharmaceutical8
- Feb 27, 2024Granted 21,440 shares of BioMarin Pharmaceutical8
- Sep 18, 2023Sold 4,359 shares at $0.69 of Nektar Therapeutics9
- Aug 16, 2023Sold 5,000 shares at $90.00 of BioMarin Pharmaceutical10
- Apr 28, 2023Granted 318 shares at $66.88 of BioMarin Pharmaceutical10
- Mar 16, 2023Shares withheld for tax 20,510 shares at $93.41 of BioMarin Pharmaceutical11
- Mar 15, 2023Shares withheld for tax 3,971 shares at $87.74 of BioMarin Pharmaceutical11
- Mar 15, 2023Granted 10,110 shares of BioMarin Pharmaceutical11
- Feb 28, 2023Granted 7,629 shares of BioMarin Pharmaceutical12
- Feb 28, 2023Granted 10,380 shares of BioMarin Pharmaceutical12
- Feb 28, 2023Granted 20,760 shares of BioMarin Pharmaceutical12
- Jan 25, 2023Sold 4,175 shares at $116.15 of BioMarin Pharmaceutical13
- Jan 25, 2023Sold 44,825 shares at $115.65 of BioMarin Pharmaceutical13
- Jan 25, 2023Exercised options 49,000 shares at $67.81 of BioMarin Pharmaceutical13
- Nov 2, 2022Sold 3,000 shares at $86.12 of BioMarin Pharmaceutical14
- Sep 23, 2022Sold 4,198 shares at $3.16 of Nektar Therapeutics15
- Sep 16, 2022Granted 10,200 shares of Nektar Therapeutics16
- Aug 11, 2022Sold 3,000 shares at $95.62 of BioMarin Pharmaceutical17
- Jun 3, 2022Shares withheld for tax 7,021 shares at $77.49 of BioMarin Pharmaceutical18
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARNektar Therapeutics, Board member
- 3
- 4
- 5
- 6SEC EDGARForm 4 filed Mar 19, 2024
- 7SEC EDGARForm 4 filed Mar 7, 2024
- 8SEC EDGARForm 4 filed Feb 29, 2024
- 9SEC EDGARForm 4 filed Sep 20, 2023
- 10SEC EDGARForm 4 filed Aug 17, 2023
- 11SEC EDGARForm 4 filed Mar 17, 2023
- 12SEC EDGARForm 4 filed Mar 2, 2023
- 13SEC EDGARForm 4 filed Jan 27, 2023
- 14SEC EDGARForm 4 filed Nov 4, 2022
- 15SEC EDGARForm 4 filed Sep 26, 2022
- 16SEC EDGARForm 4 filed Sep 20, 2022
- 17SEC EDGARForm 4 filed Aug 12, 2022
- 18SEC EDGARForm 4 filed Jun 7, 2022